Literature DB >> 26301853

Cryptosporidium and Giardia removal by secondary and tertiary wastewater treatment.

Marina Taran-Benshoshan1, Naomi Ofer, Vaizel-Ohayon Dalit, Avi Aharoni, Menahem Revhun, Yeshayahu Nitzan, Abidelfatah M Nasser.   

Abstract

Wastewater disposal may be a source of environmental contamination by Cryptosporidium and Giardia. This study was conducted to evaluate the prevalence of Cryptosporidium oocysts and Giardia cysts in raw and treated wastewater effluents. A prevalence of 100% was demonstrated for Giardia cysts in raw wastewater, at a concentration range of 10 to 12,225 cysts L(-1), whereas the concentration of Cryptosporidium oocysts in raw wastewater was 4 to 125 oocysts L(-1). The removal of Giardia cysts by secondary and tertiary treatment processes was greater than those observed for Cryptosporidium oocysts and turbidity. Cryptosporidium and Giardia were present in 68.5% and 76% of the tertiary effluent samples, respectively, at an average concentration of 0.93 cysts L(-1) and 9.94 oocysts L(-1). A higher detection limit of Cryptosporidium oocysts in wastewater was observed for nested PCR as compared to immune fluorescent assay (IFA). C. hominis was found to be the dominant genotype in wastewater effluents followed by C. parvum and C. andersoni or C. muris. Giardia was more prevalent than Cryptosporidium in the studied community and treatment processes were more efficient for the removal of Giardia than Cryptosporidium. Zoonotic genotypes of Cryptosporidium were also present in the human community. To assess the public health significance of Cryptosporidium oocysts present in tertiary effluent, viability (infectivity) needs to be assessed.

Entities:  

Keywords:  Cryptosporidium; Giardia; genotypes; removal; wastewater treatment; water reuse

Mesh:

Substances:

Year:  2015        PMID: 26301853     DOI: 10.1080/10934529.2015.1055152

Source DB:  PubMed          Journal:  J Environ Sci Health A Tox Hazard Subst Environ Eng        ISSN: 1093-4529            Impact factor:   2.269


  7 in total

Review 1.  Laboratory Diagnosis of Parasites from the Gastrointestinal Tract.

Authors:  Lynne S Garcia; Michael Arrowood; Evelyne Kokoskin; Graeme P Paltridge; Dylan R Pillai; Gary W Procop; Norbert Ryan; Robyn Y Shimizu; Govinda Visvesvara
Journal:  Clin Microbiol Rev       Date:  2017-11-15       Impact factor: 26.132

2.  Cryptosporidium Attenuation across the Wastewater Treatment Train: Recycled Water Fit for Purpose.

Authors:  Brendon King; Stella Fanok; Renae Phillips; Melody Lau; Ben van den Akker; Paul Monis
Journal:  Appl Environ Microbiol       Date:  2017-02-15       Impact factor: 4.792

3.  Comparison of pathogen-derived 'total risk' with indicator-based correlations for recreational (swimming) exposure.

Authors:  Neha Sunger; Kerry A Hamilton; Paula M Morgan; Charles N Haas
Journal:  Environ Sci Pollut Res Int       Date:  2018-04-11       Impact factor: 4.223

4.  Drivers of Microbial Risk for Direct Potable Reuse and de Facto Reuse Treatment Schemes: The Impacts of Source Water Quality and Blending.

Authors:  Rabia M Chaudhry; Kerry A Hamilton; Charles N Haas; Kara L Nelson
Journal:  Int J Environ Res Public Health       Date:  2017-06-13       Impact factor: 3.390

5.  Molecular typing of Cryptosporidium in Israel.

Authors:  Tamar Grossman; Shifra Ken-Dror; Elsa Pavlotzky; Julia Vainer; Yael Glazer; Orli Sagi; Avi Peretz; Vered Agmon; Esther Marva; Lea Valinsky
Journal:  PLoS One       Date:  2019-09-03       Impact factor: 3.240

6.  Understanding Microbial Loads in Wastewater Treatment Works as Source Water for Water Reuse.

Authors:  Hodon Ryu; Yao Addor; Nichole E Brinkman; Michael W Ware; Laura Boczek; Jill Hoelle; Jatin H Mistry; Scott P Keely; Eric N Villegas
Journal:  Water (Basel)       Date:  2021-05-21       Impact factor: 3.103

Review 7.  Wastewater-based epidemiology-surveillance and early detection of waterborne pathogens with a focus on SARS-CoV-2, Cryptosporidium and Giardia.

Authors:  Alireza Zahedi; Paul Monis; Daniel Deere; Una Ryan
Journal:  Parasitol Res       Date:  2021-01-06       Impact factor: 2.383

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.